IRIX
IRIDEX Corporation
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Sell
-27/100
Last price
0.68
▼ 0.01 (1.45%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.69
Day high
0.72
Day low
0.68
Volume
28.18K
Market cap
$11.94M
P/E (TTM)
—
52W range
0.61 – 1.65
Trailing performance
Returnvs SPY
1W
+6.25%
+4.3%
1M
-2.86%
-4.0%
3M
-39.29%
-43.8%
6M
-33.98%
-52.2%
YTD
-40.35%
-54.6%
1Y
-43.33%
-59.8%
3Y
-73.23%
-155.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on IRIX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
6.44M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 16, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 7.90K | $4.98K | Direct |
| Sep 14, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 2.35K | $1.53K | Direct |
| Sep 10, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 5.10K | $3.47K | Direct |
| Jul 10, 26 | DIZON ROMEO R Chief Financial Officer |
STOCK | 30.00K | $0 | Direct |
| Jul 10, 26 | MERCER PATRICK Chief Executive Officer |
STOCK | 100.00K | $0 | Direct |
| Jun 12, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 975 | $1.11K | Direct |
| Jun 11, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 1.68K | $1.91K | Direct |
| Jun 8, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 2.40K | $2.69K | Direct |
| Jun 5, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 2.52K | $2.90K | Direct |
| Jun 3, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 2.40K | $2.81K | Direct |
| May 26, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 5.00K | $5.00K | Direct |
| Mar 6, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 1.11K | $1.40K | Direct |
| Feb 17, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 2.20K | $2.94K | Direct |
| Feb 12, 26 | DIZON ROMEO R Chief Financial Officer |
BUY | 1.50K | $2.15K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DIZON ROMEO R |
Chief Financial Officer | 185.31K | Purchase |
HUSS BEVERLY A |
Director | 92.64K | Purchase |
MERCER PATRICK |
Chief Executive Officer | 468.78K | Stock Award(Grant) |
MOORE WILLIAM MARTIN |
Director | 402.00K | Purchase |
SHUDA SCOTT A |
Director | 129.52K | Purchase |
Fundamentals
Market cap$11.94M
Enterprise value$17.28M
Revenue (TTM)$51.57M
Gross profit$18.53M
EBITDA$-2.60M
Net income$-3.55M
EPS (TTM)$-0.20
Free cash flow$1.64M
Total cash$4.68M
Total debt$4.01M
Book value / share$-0.14
Shares outstanding17.56M
Float5.21M
Short % of float1.44%
Dividend yield0.00%
Beta (5Y)0.67
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio0.94
Price / sales—
Price / book—
EV / revenue0.34
EV / EBITDA-6.64
Gross margin35.92%
Operating margin-8.19%
Profit margin-6.88%
Return on equity-73.15%
Return on assets-5.90%
Debt / equity110.28
Current ratio1.82
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $52.67M | $48.67M | $51.87M | $56.97M | +8.2% |
| Operating revenue | $52.67M | $48.67M | $51.87M | $56.97M | +8.2% |
| Cost of revenue | $33.45M | $29.17M | $30.06M | $31.60M | +14.7% |
| Gross profit | $19.23M | $19.50M | $21.81M | $25.37M | -1.4% |
| Research & development | $3.67M | $5.45M | $6.83M | $7.17M | -32.7% |
| Selling, general & admin | $18.13M | $22.36M | $24.98M | $25.73M | -18.9% |
| Total operating expense | $21.80M | $27.80M | $31.81M | $32.91M | -21.6% |
| Operating income | -$2.57M | -$8.30M | -$10.01M | -$7.54M | +69.0% |
| Pre-tax income | -$4.38M | -$8.84M | -$9.48M | -$7.48M | +50.5% |
| Tax provision | $57.00K | $68.00K | $90.00K | $65.00K | -16.2% |
| Net income | -$4.44M | -$8.91M | -$9.57M | -$7.55M | +50.2% |
| Net income to common | -$4.44M | -$8.91M | -$9.57M | -$7.55M | +50.2% |
| Basic EPS | -0.26 | -0.54 | -0.59 | -0.47 | +51.9% |
| Diluted EPS | -0.26 | -0.54 | -0.59 | -0.47 | +51.9% |
| EBIT | -$2.57M | -$8.30M | -$10.01M | -$7.54M | +69.0% |
| EBITDA | -$1.02M | -$6.88M | -$7.97M | -$6.16M | +85.1% |
| Basic shares | 16.93M | 16.44M | 16.13M | 15.94M | +3.0% |
| Diluted shares | 16.93M | 16.44M | 16.13M | 15.94M | +3.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $6.03M | $2.39M | $7.03M | $13.92M | +152.5% |
| Cash & short-term investments | $6.03M | $2.39M | $7.03M | $13.92M | +152.5% |
| Accounts receivable | $7.61M | $5.95M | $6.73M | $6.23M | +27.9% |
| Inventory | $7.88M | $10.82M | $9.91M | $10.61M | -27.2% |
| Total current assets | $25.25M | $23.56M | $27.45M | $35.77M | +7.2% |
| Property, plant & equipment | $826.00K | $1.91M | $2.98M | $2.13M | -56.7% |
| Goodwill & intangibles | $1.95M | $2.27M | $2.61M | $2.94M | -14.2% |
| Total assets | $29.15M | $29.14M | $34.44M | $42.29M | +0.1% |
| Total current liabilities | $13.21M | $16.56M | $12.97M | $12.45M | -20.2% |
| Current debt | — | $1.73M | — | — | — |
| Long-term debt | $3.73M | $1.00M | — | — | +272.0% |
| Total debt | $4.53M | $4.64M | $2.75M | $1.77M | -2.4% |
| Total liabilities | $24.23M | $27.04M | $24.91M | $25.06M | -10.4% |
| Retained earnings | -$92.45M | -$88.01M | -$79.04M | -$69.72M | -5.0% |
| Shareholder equity | $4.92M | $2.10M | $9.52M | $17.23M | +134.7% |
| Working capital | $12.04M | $7.00M | $14.48M | $23.31M | +72.0% |
| Net tangible assets | $2.97M | -$174.00K | $6.92M | $14.29M | +1,808.6% |
| Shares issued | 17.31M | 16.64M | 16.25M | 15.99M | +4.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$4.44M | -$8.91M | -$9.57M | -$7.55M | — | +50.2% |
| Depreciation & amortisation | $1.55M | $1.42M | $2.03M | $1.38M | — | +8.6% |
| Stock-based compensation | $775.00K | $1.24M | $1.65M | $1.62M | — | -37.7% |
| Change in working capital | — | — | — | — | $12.56M | — |
| Operating cash flow | -$2.12M | -$7.29M | -$6.75M | -$9.52M | — | +71.0% |
| Capital expenditure | -$143.00K | -$13.00K | -$109.00K | -$286.00K | — | -1,000.0% |
| Investing cash flow | -$143.00K | -$13.00K | -$109.00K | -$286.00K | — | -1,000.0% |
| Financing cash flow | $5.96M | $2.60M | -$5.00K | -$73.00K | — | +128.9% |
| Free cash flow | -$2.26M | -$7.30M | -$6.85M | -$9.80M | — | +69.1% |
| End cash position | $6.03M | $2.39M | $7.03M | $13.92M | — | +152.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $12.57M | $11.80M | $14.72M | $12.48M | $13.57M | +6.5% |
| Operating revenue | $10.40M | $11.80M | $21.27M | $10.23M | $11.34M | -11.8% |
| Cost of revenue | $8.27M | $7.06M | $9.25M | $8.47M | $8.89M | +17.2% |
| Gross profit | $4.30M | $4.74M | $5.48M | $4.01M | $4.68M | -9.4% |
| Research & development | $936.00K | $905.00K | $949.00K | $972.00K | $871.00K | +3.4% |
| Selling, general & admin | $4.39M | $4.16M | $4.54M | $4.45M | $4.75M | +5.5% |
| Total operating expense | $5.33M | $5.07M | $5.49M | $5.42M | $5.62M | +5.1% |
| Operating income | -$1.03M | -$324.00K | -$15.00K | -$1.41M | -$940.00K | -217.6% |
| Pre-tax income | -$1.20M | -$466.00K | -$164.00K | -$1.57M | -$973.00K | -156.7% |
| Tax provision | $70.00K | $58.00K | $20.00K | $4.00K | $21.00K | +20.7% |
| Net income | -$1.27M | -$524.00K | -$184.00K | -$1.57M | -$994.00K | -141.6% |
| Net income to common | -$1.27M | -$524.00K | -$184.00K | -$1.57M | -$994.00K | -141.6% |
| Basic EPS | -0.07 | -0.03 | -0.01 | -0.09 | -0.06 | -133.3% |
| Diluted EPS | -0.07 | -0.03 | -0.01 | -0.09 | -0.06 | -133.3% |
| EBIT | -$1.03M | -$324.00K | -$15.00K | -$1.41M | -$940.00K | -217.6% |
| EBITDA | -$667.00K | $48.00K | $407.00K | -$1.04M | -$562.00K | -1,489.6% |
| Basic shares | 17.42M | 17.31M | 17.19M | 17.01M | 16.79M | +0.6% |
| Diluted shares | 17.42M | 17.31M | 17.19M | 17.01M | 16.79M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.68M | $4.59M | $6.03M | $5.57M | $6.78M | +1.8% |
| Cash & short-term investments | $4.68M | $4.59M | $6.03M | $5.57M | $6.78M | +1.8% |
| Accounts receivable | $5.67M | $6.84M | $7.61M | $7.13M | $7.14M | -17.1% |
| Inventory | $9.75M | $9.32M | $7.88M | $7.30M | $8.44M | +4.6% |
| Total current assets | $23.96M | $24.58M | $25.25M | $24.07M | $26.87M | -2.5% |
| Property, plant & equipment | $402.00K | $635.00K | $826.00K | $1.06M | $1.33M | -36.7% |
| Goodwill & intangibles | $1.79M | $1.87M | $1.95M | $2.03M | $2.11M | -4.2% |
| Total assets | $27.26M | $28.27M | $29.15M | $28.35M | $31.59M | -3.6% |
| Total current liabilities | $13.17M | $12.83M | $13.21M | $12.39M | $13.71M | +2.7% |
| Long-term debt | $3.79M | $3.77M | $3.73M | $3.71M | $3.67M | +0.8% |
| Total debt | $4.01M | $4.28M | $4.53M | $4.79M | $5.07M | -6.2% |
| Total liabilities | $23.62M | $23.54M | $24.23M | $23.67M | $25.53M | +0.3% |
| Retained earnings | -$94.24M | -$92.97M | -$92.45M | -$92.26M | -$90.69M | -1.4% |
| Shareholder equity | $3.64M | $4.73M | $4.92M | $4.68M | $6.06M | -23.1% |
| Working capital | $10.79M | $11.76M | $12.04M | $11.67M | $13.16M | -8.3% |
| Net tangible assets | $1.85M | $2.86M | $2.97M | $2.65M | $3.95M | -35.4% |
| Shares issued | 17.40M | 17.40M | 17.31M | 17.05M | 16.81M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$1.27M | -$524.00K | -$184.00K | -$1.57M | -$994.00K | -141.6% |
| Depreciation & amortisation | $362.00K | $372.00K | $422.00K | $366.00K | $378.00K | -2.7% |
| Stock-based compensation | $212.00K | $211.00K | $213.00K | $92.00K | $257.00K | +0.5% |
| Change in working capital | $836.00K | -$1.42M | $108.00K | -$896.00K | -$69.00K | +158.7% |
| Operating cash flow | $174.00K | -$1.33M | $589.00K | -$1.16M | -$397.00K | +113.0% |
| Capital expenditure | -$50.00K | -$101.00K | -$106.00K | -$13.00K | -$13.00K | +50.5% |
| Investing cash flow | -$50.00K | -$101.00K | -$106.00K | -$13.00K | -$13.00K | +50.5% |
| Financing cash flow | -$38.00K | -$1.00K | -$27.00K | -$34.00K | -$14.00K | -3,700.0% |
| Free cash flow | $124.00K | -$1.44M | $483.00K | -$1.17M | -$410.00K | +108.6% |
| End cash position | $4.68M | $4.59M | $6.03M | $5.57M | $6.78M | +1.8% |
Options analytics
Put / call volume
0.81
Call-heavy session
Put / call open interest
1.27
Positioning, not flow
Max pain
2.50
+267.6% from spot
ATM implied vol
50.0%
Nearest strike to spot
Skew (10% OTM)
-50.0%
Calls bid over puts
Call volume
21
Contracts, this expiry
Put volume
17
Contracts, this expiry
Heaviest call OI
7.50
14 contracts
Heaviest put OI
2.50
19 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.01 | -0.07 | -568.0% |
| Mar 2026 | -0.07 | -0.03 | +57.1% |
| Dec 2025 | -0.02 | 0.00 | +104.0% |
| Sep 2025 | — | -0.09 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.04 | 1 | $12.64M | — |
| Next quarter | 0.02 | 1 | $15.51M | +5.4% |
| Current year | -0.12 | 1 | $52.52M | -0.3% |
| Next year | 0.00 | 1 | $55.98M | +6.6% |
Analyst targets & ownership
Mean target$2.75
High target$2.75
Low target$2.75
Implied upside304.41%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders36.69%
Held by institutions19.46%
Institutions holding33
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.64
+5.92% from price
SMA 20
0.65
+5.26% from price
SMA 50
0.73
-7.38% from price
SMA 100
0.90
-24.85% from price
SMA 200
1.07
-36.66% from price
EMA 12
0.65
+4.19% from price
EMA 26
0.68
+0.65% from price
EMA 50
0.74
-8.36% from price
RSI (14)
50.5
Neutral
MACD (12,26,9)
-0.02
Hist 0.01
ATR (14)
0.03
5.15% of price
Realised vol 30D
42.8%
Annualised
Bollinger upper
0.69
20, 2σ
Bollinger lower
0.60
20, 2σ
50 / 200 cross
Death
0.73 vs 1.07
Trend bias
Below 200
-36.66%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.98
Less volatile than market
Correlation to SPY
0.19
Largely independent
Realised vol 30D
42.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-60.9%
Peak to trough
Max drawdown 5Y
-93.5%
Peak to trough
ATR 14
0.03
5.15% of price
Beta (reported)
0.67
5Y monthly, from filing
Short interest
Shares short
160.33K
Prior 37.85K
Change vs prior
+323.5%
Shorts adding
% of float
1.44%
Normal
% of shares out
0.91%
Against total outstanding
Days to cover
1.5
Liquid
Float
5.21M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 15, 24 | Stifel | MAINTAINED | Hold | Hold |
| Aug 26, 22 | Stifel | DOWNGRADE | Buy | Hold |
| May 12, 21 | Roth Capital | MAINTAINED | — | Buy |
| Mar 3, 21 | Roth Capital | MAINTAINED | — | Buy |
| Jan 13, 21 | Roth Capital | MAINTAINED | — | Buy |
| May 12, 20 | Stifel | MAINTAINED | — | Buy |
| Jan 4, 19 | Stifel | MAINTAINED | Buy | Buy |
| Oct 26, 18 | Stifel | INITIATED | — | Buy |
| Dec 21, 16 | Roth Capital | INITIATED | — | Buy |
| Jan 26, 16 | Singular Research | INITIATED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-02
Corporate Changes & Voting Matters
8-K · 2026-08-18
Corporate Changes & Voting Matters
8-K · 2026-07-16
Corporate Changes & Voting Matters
8-K · 2026-06-18
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-01
Periodic Financial Reports
10-Q · 2026-05-19
Proxy Statements
DEFA14A · 2026-04-24
Periodic Financial Reports
10-K · 2026-04-02
Headlines
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
GlobeNewswire · 2d ago
IRIDEX (IRIX) Q2 2026 Earnings Call Transcript
Motley Fool · 43d ago
IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%
Zacks · 43d ago
IRIDEX Corp (IRIX) (Q2 2026) Earnings Call Highlights: Cyclo-G6 Surges 35% as Company Achieves ...
GuruFocus.com · 49d ago
IRIDEX Corporation Q2 2026 Earnings Call Summary
Moby · 49d ago
Iridex: Q2 Earnings Snapshot
Associated Press · 50d ago
Iridex Reports Second Quarter 2026 Financial Results
GlobeNewswire · 50d ago
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
GlobeNewswire · 64d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.